In human pancreatic tumor as well as murine pancreatic lesion model, the tumor microenvironment releases CCL2 and thereby actively recruits CCR2-expressing CD14+CD16− classical monocytes from bone marrow to blood stream, which is a prognostic factor of worse outcome (45). The gene discussed is CCL2; the disease is neoplasm.